Compare TTMI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTMI | RGEN |
|---|---|---|
| Founded | 1978 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.0B |
| IPO Year | 2000 | 1995 |
| Metric | TTMI | RGEN |
|---|---|---|
| Price | $80.24 | $176.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 22 |
| Target Price | ★ $211.00 | $197.95 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 10-22-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 211.11 | ★ 286.96 |
| EPS | ★ 1.24 | 0.24 |
| Revenue | ★ $2,906,345,000.00 | $141,236,000.00 |
| Revenue This Year | $51.96 | $12.87 |
| Revenue Next Year | $32.48 | $29.67 |
| P/E Ratio | ★ $60.02 | $738.08 |
| Revenue Growth | 18.98 | ★ 35.10 |
| 52 Week Low | $55.44 | $100.99 |
| 52 Week High | $223.83 | $198.87 |
| Indicator | TTMI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 32.79 | 48.53 |
| Support Level | N/A | $158.62 |
| Resistance Level | $110.58 | $187.36 |
| Average True Range (ATR) | 8.52 | 8.73 |
| MACD | -3.93 | -0.36 |
| Stochastic Oscillator | 12.43 | 49.63 |
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.